Call Us Today! 1-855-835-7172|sales@intactgenomics.com

Intact Genomics signed a license agreement with Codex DNA

On Feb 10, 2021, Intact Genomics signed a license agreement with Codex DNA (Formerly known as Synthetic Genomics-DNA) to obtain a non-exclusive license to U.S. Patent Number 7723077 “In Vitro Recombination Method” and other patents. The license allows Intact Genomics to apply the Gibson Assembly method to develop, manufacture and sell its ig-Fusion™ cloning kit and ig-Fusion™ Cloning Enzyme Premix.  Intact Genomics propriety ig-Fusion™ cloning technology is a simple, rapid and highly efficient cloning tool.

Agrobacterium Chemically Competent Cells

On February 4th 2021, Intact Genomics announced it had developed Chemically Competent Agrobacterium Cells.  These cells will allow researchers to study agrobacterium plant transformations, without the need for an electroporator.  These new products will add variety to their robust plant-focused product offerings that already also include Agrobacterium Electrocompetent Cells, Plant Direct PCR Kits and more.

Intact Genomics Develops Products to Aid Covid-19 Research

On July 2nd, 2020, Intact Genomics announced it had recently developed a variety of products to assist researchers in their fight against COVID-19.  Recently announced products include:  FastAmp® Viral/Cell Solution, One Step RT-qPCR Kit for SARS-CoV-2 (COVID-19) detection, and T4 Enzymes (UvsX, UvsY, gp32, and Bsu).

Intact Genomics presented at Plant and Animal Genome Conference (PAG) on Jan 11-15, 2020

Visit us at Booth 227, and talk with our sales director, Mr. Andy Robertson, and/or CEO, Dr. Chengcang Wu to learn more about our new products, services and technologies. We provide superior molecular biology research tools including agrobacterium competent cells, recombinase polymerase amplification (RPA) optimization enzymes, plant direct PCR kits and custom genomic services to meet your research needs and serve worldwide plant and animal genome R&D community.

Intact Genomics Awarded the Patent of Fungal Artificial Chromosome Technologies

On September 25th, 2019, Intact Genomics announced that the United States Patent and Trademark Office (USPTO) has issued a new patent of “Fungal Artificial Chromosomes, Compositions, Methods and Uses Therefor” (U.S. Patent No. 10,337,019) to Intact Genomics. The patent covers Fungal artificial chromosome (FAC) vectors which can be replicated in a bacterial or a fungal host and can comprise an insert of heterologous DNA up to 300-500 kilobases into a fungal genome. The insert sequence can be modified by homologous recombination. Fungal artificial chromosome (FAC) vectors also can be a plasmid comprising bacterial and fungal origins of replication, as well as bacterial and fungal selection marker genes. Additionally, the patent discloses the methods of generating plasmid libraries including vectors comprising intact SM gene clusters. For more information, click this press release from STLtoday.

Intact Genomics attended “Genomics of Energy & Environment Meeting” hosted by Joint Genome Institute (JGI).

Intact Genomics attended “Genomics of Energy & Environment Meeting” hosted by Joint Genome Institute (JGI).
Dr. Chengcang Wu, a Distinguished Scientist from Intact Genomics attended “Genomics of Energy & Environment Meeting” hosted by Joint Genome Institute (JGI) in San Francisco, California from April 2 to April 5, 2019.
Intact Genomics had a poster presentation titled “Unearth Novel Anti-MRSA Antibiotics from Extremophilic Fungi from a Toxic Pit” at the meeting.

Intact Genomics Awarded NIH SBIR Fast-Track Grant to Develop Novel Technology for New Natural Product Discovery

On January 15, 2019, Intact Genomics, Inc. announced that it has received a Small Business Innovation Research (SBIR) Fast-Track grant from the National Institute of Allergy and Infectious Diseases of the National Institute of Health. Intact Genomics will use its unique FAC technology and next-generation sequencing technologies (FAC-NGS as tools) to develop new technologies which can rapidly discover thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi.

Intact Genomics Presented at NIH IntraMall Fall Showcase

Intact Genomics presented at the NIH IntraMalls Fall Showcase on November 14, 2018. Mr. Andrew Robertson, Sales Director of Intact Genomics, hosted a booth for NIH scientists to learn about our new products and technologies. Intact Genomics was founded in 2013 in St. Louis, MO. We provide high-quality life science products and genomic services to help scientists explore the genome structure and function of microorganisms, plants and animal species. All products are manufactured in St. Louis, Missouri by our talented team of Scientists with core beliefs based on quality, innovation, and unwavering commitment customer satisfaction.

Intact Genomics Won the Polsinelli Award at Startup Connection Venture Showcase 2018

Intact Genomics was selected to the Startup Connection Venture Showcase. Startup Connection gives St. Louis’ top startups the opportunity to present their companies to a packed house of entrepreneurs, investors, and other members of the innovation community. The event combines a startup showcase and a resource fair. It attracted more than 1,200 entrepreneurs, investors, business people, scientists and students interested St. Louis innovation scene on November 7, 2018. Intact Genomics won the Polsinelli Award.

Go to Top